EU Launches Joint Scientific Consultations to E...

By João L. Carapinha

January 14, 2026

Launching Joint Scientific Consultations in 2026 The European Commission has initiated the first submission period for Joint Scientific Consultations under the EU Health Technology As...

NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...

Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...

Key Decisions on Health Technology Assessment at ACP124: Implications for Rar...

Dutch Pharmacoeconomic Redesign: Streamlined Structure and Enhanced Transpare...

Revolutionizing Pharmacoeconomic Evaluations Nederland: Zorginstituut’s...

DALY Modeling Methods for Enhanced Health Economics and Policy Analysis

Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges

Implementing Health Technology Assessment in Oman

Surrogate Endpoints Guidance: New International Report Enhances HTA Practices

Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate

Boosting Biopharma SMEs in Europe

NICE Rejects Donanemab for NHS Use Due to Cost Concerns